Lung sparing in MR-guided non-adaptive SBRT treatment of peripheral lung tumors

医学 核医学 肺癌 肺容积 放射治疗计划 放射治疗 放射科 磁共振成像 内科学
作者
Ho Young Lee,Grace Lee,D. Ferguson,Shu‐Hui Hsu,Yue-Houng Hu,Elizabeth Huynh,Atchar Sudhyadhom,Christopher L. Williams,D.N. Cagney,Kelly Fitzgerald,Benjamin H. Kann,David Kozono,Jonathan E. Leeman,Raymond H. Mak,Zhaohui Han
出处
期刊:Biomedical Physics & Engineering Express [IOP Publishing]
卷期号:10 (4): 045048-045048 被引量:1
标识
DOI:10.1088/2057-1976/ad567d
摘要

Abstract Objective. We aim to: (1) quantify the benefits of lung sparing using non-adaptive magnetic resonance guided stereotactic body radiotherapy (MRgSBRT) with advanced motion management for peripheral lung cancers compared to conventional x-ray guided SBRT (ConvSBRT); (2) establish a practical decision-making guidance metric to assist a clinician in selecting the appropriate treatment modality. Approach. Eleven patients with peripheral lung cancer who underwent breath-hold, gated MRgSBRT on an MR-guided linear accelerator (MR linac) were studied. Four-dimensional computed tomography (4DCT)-based retrospective planning using an internal target volume (ITV) was performed to simulate ConvSBRT, which were evaluated against the original MRgSBRT plans. Metrics analyzed included planning target volume (PTV) coverage, various lung metrics and the generalized equivalent unform dose (gEUD). A dosimetric predictor for achievable lung metrics was derived to assist future patient triage across modalities. Main results. PTV coverage was high (median V100% > 98%) and comparable for both modalities. MRgSBRT had significantly lower lung doses as measured by V20 (median 3.2% versus 4.2%), mean lung dose (median 3.3 Gy versus 3.8 Gy) and gEUD. Breath-hold, gated MRgSBRT resulted in an average reduction of 47% in PTV volume and an average increase of 19% in lung volume. Strong correlation existed between lung metrics and the ratio of PTV to lung volumes (R PTV/Lungs ) for both modalities, indicating that R PTV/Lungs may serve as a good predictor for achievable lung metrics without the need for pre-planning. A threshold value of R PTV/Lungs < 0.035 is suggested to achieve V20 < 10% using ConvSBRT. MRgSBRT should otherwise be considered if the threshold cannot be met. Significance. The benefits of lung sparing using MRgSBRT were quantified for peripheral lung tumors; R PTV/Lungs was found to be an effective predictor for achievable lung metrics across modalities. R PTV/Lungs can assist a clinician in selecting the appropriate modality without the need for labor-intensive pre-planning, which has significant practical benefit for a busy clinic.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
刚刚
好久不见发布了新的文献求助10
刚刚
科研通AI6.2应助caixk采纳,获得10
1秒前
预则立完成签到,获得积分10
2秒前
2秒前
2秒前
liu发布了新的文献求助10
4秒前
乐乐应助lcj1014采纳,获得10
4秒前
zzz发布了新的文献求助10
5秒前
5秒前
舒舒服服水完成签到,获得积分10
6秒前
6秒前
万能图书馆应助heheheli采纳,获得10
6秒前
FashionBoy应助heheheli采纳,获得10
6秒前
搜集达人应助heheheli采纳,获得10
6秒前
Owen应助heheheli采纳,获得10
6秒前
bibler发布了新的文献求助10
8秒前
酷波er应助彩色芝采纳,获得10
8秒前
星野Nana_发布了新的文献求助10
8秒前
8秒前
8秒前
天人旧馆发布了新的文献求助10
9秒前
9秒前
9秒前
呆呆颖发布了新的文献求助10
11秒前
鲤鱼青雪发布了新的文献求助10
11秒前
12秒前
12秒前
LMH发布了新的文献求助10
12秒前
jay555发布了新的文献求助10
12秒前
希望天下0贩的0应助3152采纳,获得10
14秒前
XIE发布了新的文献求助80
14秒前
CodeCraft应助自觉千柔采纳,获得10
16秒前
16秒前
555完成签到,获得积分10
16秒前
好久不见发布了新的文献求助10
17秒前
所所应助追寻紫安采纳,获得10
18秒前
lcj1014发布了新的文献求助10
18秒前
lml发布了新的文献求助10
19秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Developing Genetic Editing Tools for Lysobacter 2000
Моделирование процессов самоорганизации в кристаллообразующих системах 1000
Adhesion Science: Principles & Practice 800
Signals, Systems, and Signal Processing 610
IEST-RP-CC018: Cleanroom Cleaning and Sanitization: Operating and Monitoring Procedures 600
Fundamentals of Pharmaceutical and Biologics Regulations: A Global Perspective, Second Edition 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6528008
求助须知:如何正确求助?哪些是违规求助? 8321087
关于积分的说明 17812932
捐赠科研通 5629615
什么是DOI,文献DOI怎么找? 2930546
邀请新用户注册赠送积分活动 1907257
关于科研通互助平台的介绍 1766657